Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CYM5181

Copy Product Info
😃Good
Catalog No. T31149Cas No. 695155-81-8
Alias CYM-5181, CYM 5181

CYM5181 is related to the body's immune system and can be used to study multiple sclerosis, transplant rejection, and adult respiratory distress syndrome.

CYM5181

CYM5181

Copy Product Info
😃Good
Purity: 99.51%
Catalog No. T31149Alias CYM-5181, CYM 5181Cas No. 695155-81-8
CYM5181 is related to the body's immune system and can be used to study multiple sclerosis, transplant rejection, and adult respiratory distress syndrome.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$147In StockIn Stock
5 mg$348In StockIn Stock
10 mg$475In StockIn Stock
25 mg$667In StockIn Stock
50 mg$826In StockIn Stock
100 mg$1,050In StockIn Stock
200 mg$1,370-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.51%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

CYM5181 AI Summary
CYM5181 exhibits diverse bioactivities with varying potencies across multiple assays. It demonstrates inhibitory activity against Tau fibril formation and IMPase, with potencies of 5623.4 nM and 35481.3 nM, respectively. Additionally, it shows activating properties in assays related to p53 reactivation (56234.1 nM) and BRCA1 expression (11220.2 nM). The compound acts as an inverse agonist for the GLP-1 receptor with a potency of 1584.9 nM and manifests agonist activity for the gsp mutation responsible for Fibrous Dysplasia/McCune-Albright Syndrome at 10000.0 nM. Moreover, it inhibits Vaccinia Orthopoxvirus with a potency of 5011.9 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CYM5181 is related to the body's immune system and can be used to study multiple sclerosis, transplant rejection, and adult respiratory distress syndrome.
SynonymsCYM-5181, CYM 5181
Chemical Properties
Molecular Weight311.34
FormulaC17H17N3O3
Cas No.695155-81-8
SmilesCCOC1=C(OCC)C=C(C=C1)C1=NC(=NO1)C1=CC=NC=C1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 2.19 mg/mL (7.03 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2119 mL16.0596 mL32.1192 mL160.5961 mL
5 mM0.6424 mL3.2119 mL6.4238 mL32.1192 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CYM5181 | purchase CYM5181 | CYM5181 cost | order CYM5181 | CYM5181 chemical structure | CYM5181 formula | CYM5181 molecular weight